Kelly Bliss - 27 Feb 2026 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
President, U.S. Group Health
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol
TDOC
Transactions as of
27 Feb 2026
Net transactions value
-$136,353
Form type
4
Filing time
03 Mar 2026, 16:08:40 UTC
Previous filing
03 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bliss Kelly President, U.S. Group Health C/O TELADOC HEALTH, INC.,, 155 E 44TH ST, SUITE 1700, NEW YORK /s/ Adam C. Vandervoort, Attorney-in-Fact 03 Mar 2026 0002036989
This filing has been restated, see here for the amended filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +3,488 +5.8% 63,542 27 Feb 2026 Direct F1
transaction TDOC Common Stock Options Exercise +4,858 +7.6% 68,400 27 Feb 2026 Direct F1
transaction TDOC Common Stock Options Exercise +36,610 +54% 105,010 27 Feb 2026 Direct F1
transaction TDOC Common Stock Options Exercise +1,186 +1.1% 106,196 27 Feb 2026 Direct F2
transaction TDOC Common Stock Options Exercise +5,198 +4.9% 111,394 27 Feb 2026 Direct F2
transaction TDOC Common Stock Sale $136,353 -26,647 -24% $5.12 84,747 02 Mar 2026 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -3,488 -100% $0.000000 0 27 Feb 2026 Common Stock 3,488 Direct F1, F4
transaction TDOC Restricted Stock Units Options Exercise $0 -4,858 -20% $0.000000 19,435 27 Feb 2026 Common Stock 4,858 Direct F1, F5
transaction TDOC Restricted Stock Units Options Exercise $0 -36,610 -33% $0.000000 73,222 27 Feb 2026 Common Stock 36,610 Direct F1, F6
transaction TDOC Performance Stock Units Options Exercise $0 -1,186 -100% $0.000000 0 27 Feb 2026 Common Stock 1,186 Direct F2, F7
transaction TDOC Performance Stock Units Award $0 +27,458 $0.000000 27,458 27 Feb 2026 Common Stock 27,458 Direct F8, F9, F10
transaction TDOC Performance Stock Units Options Exercise $0 -5,198 -19% $0.000000 22,260 27 Feb 2026 Common Stock 5,198 Direct F2, F11
transaction TDOC Restricted Stock Units Award $0 +181,661 $0.000000 181,661 01 Mar 2026 Common Stock 181,661 Direct F12, F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F3 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4 On March 3, 2023, the reporting person was granted 41,853 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F5 On March 19, 2024, the reporting person was granted 58,300 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.
F6 On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F7 On March 1, 2024, the reporting person earned 14,263 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F8 Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
F9 Performance award amount determined based on metrics in respect of the issuer's 2025 financial results.
F10 The performance stock units vest as to one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F11 On March 1, 2026, the reporting person earned 27,458 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F12 Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F13 One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.